Abstract
Purpose
This study aimed to estimate the health preference–based index scores of the population of patients with lymphoma using the EQ-5D in China.
Methods
A cross-sectional online survey was conducted to examine the health and well-being of patients with lymphoma in China. Their health-related quality of life (HRQoL; using the EQ-5D), demographic and socioeconomic characteristics, and health conditions were assessed. The data were analyzed using Pearson’s χ2 test, analysis of variance, and binary logistic and Tobit regression models.
Results
A total of 3261 patients (sex: men = 58.5%, age: < 30 years = 9.5% and > 60 years = 24.6%) participated in the study. The mean EQ-5D-5L index and EQ-VAS scores were 0.83 and 68.8, respectively. Binary logistic regression analysis revealed that women reported more pain-related problems than men did. Unemployed participants were substantially more likely to report health problems on all the five dimensions of the EQ-5D than their employed counterparts. The Tobit regression model revealed that respondents who were older, unemployed, with low income, received chemotherapy, and with short durations reported a low index score.
Conclusion
Using the EQ-5D, the preference-based scores of different subpopulations of patients with lymphoma may support economic evaluation by promoting the simultaneous consideration of both the reasonable use of resources and satisfactory achievement of health outcomes.
Similar content being viewed by others
Data availability
Data may be approached by contact with correspondence author.
References
Center for disease control and prevention. Lymphoma. https://www.cdc.gov/cancer/lymphoma/index.htm
Lymphoma Action. What is lymphoma? https://lymphoma-action.org.uk/about-lymphoma/what-lymphoma
Cancer Council Australia. Lymphoma. http://www.cancer.org.au/about-cancer/types-of-cancer/lymphoma.html
Center for disease control and prevention. Leading Cancer Cases and Deaths. https://gis.cdc.gov/Cancer/USCS/DataViz.html
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132. https://doi.org/10.3322/caac.21338
Doolittle N, Korfel A, Lubow MA et al (2013) Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology 81:84–92
Brazier J, Yang Y, Tsuchiya A et al (2010) A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Heal Econ Prev Care 11:215–225. https://doi.org/10.1007/s10198-009-0168-z
Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). An Int J Qual Life Asp Treat Care Rehabil 20:1727–1736. https://doi.org/10.1007/s11136-011-9903-x
Sullivan PW, Ghushchyan VH (2016) EQ-5D scores for diabetes-related comorbidities. Value Heal 19:1002–1008. https://doi.org/10.1016/j.jval.2016.05.018
Rencz F, Gulácsi L, Drummond M, Golicki D, Prevolnik Rupel V, Simon J, Stolk EA, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Péntek M (2016) EQ-5D in Central and Eastern Europe: 2000–2015. Qual Life Res 25:2693–2710. https://doi.org/10.1007/s11136-016-1375-6
Rowen D, Azzabi Zouraq I, Chevrou-Severac H, van Hout B (2017) International regulations and recommendations for utility data for health technology assessment. Pharmacoeconomics 35:11–19. https://doi.org/10.1007/s40273-017-0544-y
Ramsey SD, Nademanee A, Masszi T, Holowiecki J, Abidi M, Chen A, Stiff P, Viviani S, Sweetenham JW, Radford J, Zhu Y, Bonthapally V, Thomas E, Richhariya A, Hunder NN, Walewski J, Moskowitz CH (2016) Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma. Br J Haematol 175:860–867. https://doi.org/10.1111/bjh.14316
Glaser AW, Fraser LK, Corner J, Feltbower R, Morris EJ, Hartwell G, Richards M, Wagland R (2013) Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey. BMJ Open 3:e002317. https://doi.org/10.1136/bmjopen-2012-002317
Wang H, Smith A, Yu G, Aas E, Bagguley T, Howell D, Roman E, Burton C, Patmore R (2017) PCN203 - UK utility elicitation in patients with follicular lymphoma. Value Heal 20:A449–A449. https://doi.org/10.1016/j.jval.2017.08.286
Jefford M, Ward A, Lisy K et al (2017) Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. Support Care Cancer 25:3171–3179. https://doi.org/10.1007/s00520-017-3725-5
Davies A, Waylen A, Leary S, Thomas S, Pring M, Janssen B, Beynon R, Lang S, Schimansky S, Hurley K, Ness A (2020) Assessing the validity of EQ-5D-5L in people with head & neck cancer: does a generic quality of life measure perform as well as a disease-specific measure in a patient population? Oral Oncol 101:104504. https://doi.org/10.1016/j.oraloncology.2019.104504
Cheung Y, Thumboo J (2006) Developing health-related quality-of-life instruments for use in Asia. Pharmacoeconomics 24:643–650. https://doi.org/10.2165/00019053-200624070-00003
Sitlinger A, Zafar SY (2018) Health-related quality of life: the impact on morbidity and mortality. Surg Oncol Clin N Am 27:675–684. https://doi.org/10.1016/j.soc.2018.05.008
Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K (2017) Estimating an EQ-5D-5L value set for China. Value Heal 20:662–669. https://doi.org/10.1016/j.jval.2016.11.016
Mair P, Wilcox R (2018;forthcoming) Robust statistical methods Using WRS2. J Stat Softw. https://doi.org/10.18637/jss.v000.i00
Norum J, Angelsen V, Wist E, Olsen JA (1996) Treatment costs in Hodgkin’s disease: a cost-utility analysis. Eur J Cancer 32:1510–1517. https://doi.org/10.1016/0959-8049(96)00142-6
Pickard AS, Jiang R, Lin H-W, Rosenbloom S, Cella D (2016) Using patient-reported outcomes to compare relative burden of cancer: EQ-5D and functional assessment of cancer therapy-general in eleven types of Cancer. Clin Ther 38:769–777. https://doi.org/10.1016/j.clinthera.2016.03.009
Crott R, Versteegh M, Uyl-de-Groot C (2013) An assessment of the external validity of mapping QLQ-C30 to EQ-5D preferences. An Int J Qual Life Asp Treat Care Rehabil 22:1045–1054. https://doi.org/10.1007/s11136-012-0220-9
Brandt J, Dietrich S, Meissner J, Neben K, Ho AD, Witzens-Harig M (2010) Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leuk Lymphoma 51:2012–2020. https://doi.org/10.3109/10428194.2010.513749
Wong ELY, Xu RH, Cheung AWL (2019) Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China. BMJ Open 9:e032544. https://doi.org/10.1136/bmjopen-2019-032544
Daniëls LA, Oerlemans S, Krol ADG, Creutzberg CL, van de Poll-Franse LV (2014) Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer 110:868–874. https://doi.org/10.1038/bjc.2013.779
Oerlemans S, Mols F, Nijziel M et al (2014) The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. Res Pract 8:555–564. https://doi.org/10.1007/s11764-014-0367-1
Baeza-Velasco C, Baguet F, Allart P, Aguerre C, Sultan S, Ninot G, Soubeyran P, Cousson-Gelie F (2017) Major depressive disorder and associated factors in elderly patients with non-Hodgkin’s lymphoma. Heal Psychol Behav Med 5:57–65. https://doi.org/10.1080/21642850.2016.1264879
Casellas-Grau A, Ochoa C, Ruini C (2017) Psychological and clinical correlates of posttraumatic growth in cancer: a systematic and critical review. Psycho-Oncology 26:2007–2018. https://doi.org/10.1002/pon.4426
Weiss Wiesel TR, Nelson CJ, Tew WP, Hardt M, Mohile SG, Owusu C, Klepin HD, Gross CP, Gajra A, Lichtman SM, Ramani R, Katheria V, Zavala L, Hurria A, On behalf of the Cancer Aging Research Group (CARG) (2015) The relationship between age, anxiety, and depression in older adults with cancer. Psycho-Oncology 24:712–717. https://doi.org/10.1002/pon.3638
Kim SH, Lee S, Kim SH, Ok ON, Kim IR, Choi E, Kang YK, Kim SJ, Lee MH (2017) Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life. Psycho-Oncology 26:330–336. https://doi.org/10.1002/pon.4136
Holahan HM, Farah RS, Fitz S, Mott SL, Ferguson NN, McKillip J, Link B, Liu V (2018) Health-related quality of life in patients with cutaneous T-cell lymphoma? Int J Dermatol 57:1314–1319. https://doi.org/10.1111/ijd.14132
Short Farley P, Mallonee L (2006) E. Income disparities in the quality of life of cancer survivors. Med Care 44:16–23
Marmot M (2002) The influence of income on health: views of an epidemiologist. Health Aff 21:31–46. https://doi.org/10.1377/hlthaff.21.2.31
Loh DA, Moy FM, Zaharan NL, Mohamed Z (2015) Disparities in health-related quality of life among healthy adolescents in a developing country – the impact of gender, ethnicity, socio-economic status and weight status. Child Care Health Dev 41:1216–1226. https://doi.org/10.1111/cch.12252
Vargo JA, Gill BS, Balasubramani GK, Beriwal S (2015) Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: do we still need consolidative radiotherapy? J Clin Oncol 33:3710–3717. https://doi.org/10.1200/JCO.2015.61.7654
American cancer society. Radiation therapy for Hodgkin lymphoma. https://www.cancer.org/cancer/non-hodgkin-lymphoma/treating/radiation-therapy.html. Accessed 1 May 2020
Castellino SM, Parsons SK, Kelly KM (2019) Closing the survivorship gap in children and adolescents with Hodgkin lymphoma. Br J Haematol 187:573–587. https://doi.org/10.1111/bjh.16197
Acknowledgments
The authors would like to thank House086 and all participants who helped with the study.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by DD and RX. The first draft of the manuscript was written by RX. DD revised the first draft. Other authors commented on all versions of the manuscript and helped improve it. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest
Code availability
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 81 kb)
Rights and permissions
About this article
Cite this article
Xu, R.H., Wong, E.Ly., Jin, J. et al. Health-related quality of life measured using EQ-5D in patients with lymphomas. Support Care Cancer 29, 2549–2560 (2021). https://doi.org/10.1007/s00520-020-05774-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05774-6